Search research articles
Contact Us
Filters
Showing results (521-530 of 672) with videos related to
Page
of 68
Sort By:
Journal of Medicinal Chemistry
|
December 12, 2017
Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders
Mu-Fa Zou, Jianjing Cao, Ara M Abramyan, et al.
Leukemia
|
March 12, 2016
Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras
J Akutagawa, T Q Huang, I Epstein, et al.
Translational Oncology
|
July 25, 2019
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
Allison R Hanaford, Jesse Alt, Rana Rais, et al.
Journal of Medicinal Chemistry
|
February 14, 2014
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase
Dana Ferraris, Bridget Duvall, Greg Delahanty, et al.
The Journal of Clinical Investigation
|
March 17, 2025
ATGL links insulin dysregulation to insulin resistance in adolescents with obesity and hepatosteatosis
Aaron L Slusher, Nicola Santoro, Alla Vash-Margita, et al.
Cancers
|
March 10, 2022
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways
Khoa Pham, Allison R Hanaford, Brad A Poore, et al.
Diabetes
|
August 5, 2009
FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages
Dongming Su, Gina M Coudriet, Dae Hyun Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 5, 2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease
Abhijit A Date, Rana Rais, Taarika Babu, et al.
Journal of Medicinal Chemistry
|
May 12, 2006
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain
Pavel Majer, Bunda Hin, Doris Stoermer, et al.
Bioorganic & Medicinal Chemistry
|
October 17, 2020
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker
Bridget Duvall, Sarah C Zimmermann, Run-Duo Gao, et al.
Page
of 68
Search research articles
Search
Showing results (521-530 of 672) with videos related to
Sort By:
Page
of 68
Journal of Medicinal Chemistry
|
December 12, 2017
Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders
Mu-Fa Zou, Jianjing Cao, Ara M Abramyan, et al.
Leukemia
|
March 12, 2016
Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras
J Akutagawa, T Q Huang, I Epstein, et al.
Translational Oncology
|
July 25, 2019
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
Allison R Hanaford, Jesse Alt, Rana Rais, et al.
Journal of Medicinal Chemistry
|
February 14, 2014
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase
Dana Ferraris, Bridget Duvall, Greg Delahanty, et al.
The Journal of Clinical Investigation
|
March 17, 2025
ATGL links insulin dysregulation to insulin resistance in adolescents with obesity and hepatosteatosis
Aaron L Slusher, Nicola Santoro, Alla Vash-Margita, et al.
Cancers
|
March 10, 2022
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways
Khoa Pham, Allison R Hanaford, Brad A Poore, et al.
Diabetes
|
August 5, 2009
FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages
Dongming Su, Gina M Coudriet, Dae Hyun Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 5, 2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease
Abhijit A Date, Rana Rais, Taarika Babu, et al.
Journal of Medicinal Chemistry
|
May 12, 2006
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain
Pavel Majer, Bunda Hin, Doris Stoermer, et al.
Bioorganic & Medicinal Chemistry
|
October 17, 2020
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker
Bridget Duvall, Sarah C Zimmermann, Run-Duo Gao, et al.
Page
of 68